Latest Conference Articles

Do you know the current guidelines for using dual antiplatelet therapy after drug-eluting stent implantation?

Pharmacists should learn how to properly diagnose foreign-acquired diseases in order to optimize outcomes for infected patients.

Matthew C. Grissinger, RPh, FISMP, FASCP, director, of error reporting programs at the Institute for Safe Medication Practices, discusses medication use risk outside the pharmacy.

Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses what the role of the pharmacist is in acute coronary syndrome management with platelet aggregation inhibitors.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of platelet aggregation inhibitors in ACS management.

Identifying medication use risks outside the hospital pharmacy requires something simple: speaking with other members of the health care team.

Health-system pharmacists must look beyond immediate operational challenges and consider the larger trends that will ultimately affect their practices.

James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, describes how the growing trend of patient empowerment will affect the practice of pharmacy going forward.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the different nuances pharmacists have to consider when using platelet aggregation inhibitors in different patient populations.

Pharmacists should take advantage of the FDA's adverse drug event reporting system to promote patient safety.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the pharmacist's role in acute coronary syndrome management with platelet aggregation inhibitors.

Certain items are must-haves in any crash cart during a hospital code.

Natasha Nicol, Pharm D, FASHP, director of Global Patient Safety Affairs at Cardinal Health, discusses internal and external factors that could affect pharmacists' reliability.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses some ways pharmacists can help in cardiopulmonary resuscitation efforts.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, talks about what is inside a crash cart.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the role pharmacists can play in emergency situations.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses what is in a crash cart beyond medications.

Patrick Dougherty, PharmD, BCPS, a clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, gives some examples of treatment for minor burns.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of the pharmacist in ACS management with platelet aggregation inhibitors.

Patrick Dougherty, PharmD, BCPS, a clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, discusses how pharmacists can help burn patients.

Health-system pharmacists can help save lives by reducing the risk of medication errors before, during, and after hospital emergency codes.

Should hospitals open their own medical marijuana dispensaries?

Matthew C. Grissinger, RPh, FISMP, FASCP, director, of error reporting programs at the Institute for Safe Medication Practices, discusses what the pharmacist's role is in managing the medication process outside the pharmacy.

The secrets to pharmacy success can be obtained by changing the way in which one views the pharmacy business.

Pharmacy Development Services (PDS), the leading provider of business education for independent pharmacy owners, has announced the ten recipients of the 2015 PDS Conference Showcase of Success. For the past nine years, the Showcase of Success segment has been an integral part of the annual business growth conference as a way to demonstrate the opportunities for real results in the industry.

Pharmacy Development Services has announced an exceptional line-up of professional keynote speakers for its 11th annual independent business growth conference in 2015. The PDS Conference will take place from February 18 " 21, 2015 at the Renaissance Hotel in Orlando, Florida.

Researchers at the American Epilepsy Society meeting reported important strides in the understanding of epilepsy, including identification of new therapeutic targets in the brain, as discussed by Esther Krook-Magnuson, PhD, as well as improved understanding of the factors involved in sudden death of patients with epilepsy, and a greater recognition of the benefits of neurosurgery in patients with epilepsy.

Several new antiepileptic drugs have recently been approved in the United States. In a symposium at the American Epilepsy Society in Seattle, Washington, Professor Martin J. Brodie, MD, director of the epilepsy unit of the Western Infirmary in Glasgow, Scotland, discussed some considerations with ezogabine and eslicarbazepine.